SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-016823
Filing Date
2024-02-12
Accepted
2024-02-12 20:30:49
Documents
1
Group Members
XIAOYING TIAN

Document Format Files

Seq Description Document Type Size
1 SC 13G tm245941d1_sc13g.htm SC 13G 62900
  Complete submission text file 0001104659-24-016823.txt   64955
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13G | Act: 34 | File No.: 005-88797 | Film No.: 24622214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 919 CONGRESS AVENUE SUITE 830 AUSTIN TX 78701
Business Address 919 CONGRESS AVENUE SUITE 830 AUSTIN TX 78701 415-738-4435
Saturn V Capital Management LP (Filed by) CIK: 0001964437 (see all company filings)

IRS No.: 862769060 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G